InBody
인바디 · 041830
Health Care Medical Devices · KOSDAQ
Market cap US$417.6M (₩576.3B)
Overview
InBody makes body-composition analyzers, medical devices that measure how much muscle, fat, and water a person's body contains, along with automatic blood-pressure monitors, height-measuring instruments, and related software.
Its customers include hospitals, fitness centers, obesity clinics, military units, schools, government offices, and individual consumers. Listed on KOSDAQ, Korea's tech-focused stock exchange, InBody operates through subsidiaries across multiple continents, and the large majority of its revenue comes from markets outside Korea, with professional-grade body-composition analyzers accounting for the dominant share of total sales.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$123.4M
- FY2024US$148.2M
- FY2025US$169.5M
Operating profit
- FY2023US$27.8M
- FY2024US$26.6M
- FY2025US$26.6M
Net income
- FY2023US$26.5M
- FY2024US$23.7M
- FY2025US$21.7M
Key ratios (FY2025)
Why it matters
InBody is structured as a global group with domestic and overseas subsidiaries, over a dozen foreign entities spanning the Americas, Europe, and Asia-Pacific.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?